{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:06:50Z","timestamp":1791295610459,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T00:00:00Z","timestamp":1518134400000},"content-version":"vor","delay-in-days":1135,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Programme National de Recherche Cardiovasculaire"},{"name":"R\u00e9gion Lorraine"},{"name":"6th EU-FP Network of Excellence Ingenious HyperCare","award":["LSHM-CT-2006\u2013037093"],"award-info":[{"award-number":["LSHM-CT-2006\u2013037093"]}]},{"name":"FP7 HOMAGE","award":["FP7 305507"],"award-info":[{"award-number":["FP7 305507"]}]},{"name":"FIBRO-TARGETS","award":["FP7 602904"],"award-info":[{"award-number":["FP7 602904"]}]},{"name":"Fondo de Investigaciones Sanitarias","award":["PI12\/01729"],"award-info":[{"award-number":["PI12\/01729"]}]},{"name":"Red de Investigaci\u00f3n Cardiovascular","award":["RD12\/0042\/0033"],"award-info":[{"award-number":["RD12\/0042\/0033"]}]},{"DOI":"10.13039\/100015282","name":"BG Medicine","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015282","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Miguel Servet","award":["CP13\/00221"],"award-info":[{"award-number":["CP13\/00221"]}]},{"DOI":"10.13039\/100015282","name":"BG Medicine","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015282","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015282","name":"BG Medicine","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015282","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jchf.2014.08.002","type":"journal-article","created":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T19:18:29Z","timestamp":1415733509000},"page":"59-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":193,"title":["The Impact of Galectin-3 Inhibition on\u00a0Aldosterone-Induced Cardiac and Renal\u00a0Injuries"],"prefix":"10.1016","volume":"3","author":[{"given":"Laurent","family":"Calvier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Martinez-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Miana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Cachofeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Rafael","family":"S\u00e1daba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"L\u00f3pez-Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2014.08.002_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0039-128X(99)00087-2","article-title":"Mineralocorticoid action","volume":"65","author":"Rogerson","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.jchf.2014.08.002_bib2","doi-asserted-by":"crossref","first-page":"H2372","DOI":"10.1152\/ajpheart.00283.2011","article-title":"A\u00a0role for cardiotrophin-1 in myocardial remodeling induced by aldosterone","volume":"301","author":"L\u00f3pez-Andr\u00e9s","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jchf.2014.08.002_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrneph.2010.30","article-title":"Aldosterone: effects on the kidney and cardiovascular system","volume":"6","author":"Briet","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jchf.2014.08.002_bib4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jsbmb.2008.03.005","article-title":"Aldosterone and the vascular system","volume":"109","author":"Cachofeiro","year":"2008","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jchf.2014.08.002_bib5","doi-asserted-by":"crossref","first-page":"16633","DOI":"10.1074\/jbc.M109.008748","article-title":"Aldosterone stimulates elastogenesis in cardiac fibroblasts via mineralocorticoid receptor-independent action involving the consecutive activation of Galpha13, c-Src, the insulin-like growth factor-I receptor, and phosphatidylinositol 3-kinase\/Akt","volume":"284","author":"Bunda","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jchf.2014.08.002_bib6","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/cbin.10082","article-title":"Rho kinase pathway is likely responsible for the profibrotic actions of aldosterone in renal epithelial cells via inducing epithelial-mesenchymal transition and extracellular matrix excretion","volume":"37","author":"Wei","year":"2013","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.jchf.2014.08.002_bib7","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1161\/CIRCRESAHA.112.278457","article-title":"Cardiorenal syndrome: the emerging role of protein-bound uremic toxins","volume":"111","author":"Lekawanvijit","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.jchf.2014.08.002_bib8","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbagen.2005.12.020","article-title":"Galectin-3: an open-ended story","volume":"1760","author":"Dumic","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jchf.2014.08.002_bib9","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.carres.2008.08.038","article-title":"Modified citrus pectin anti-metastatic properties: one bullet, multiple targets","volume":"344","author":"Glinsky","year":"2009","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.jchf.2014.08.002_bib10","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cellbi.2006.11.036","article-title":"Expression and immunohistochemical localization of galectin-3 in various mouse tissues","volume":"31","author":"Kim","year":"2007","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.jchf.2014.08.002_bib11","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2014.08.002_bib12","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1016\/j.transproceed.2011.10.050","article-title":"Galectin-3 enhances proliferation and angiogenesis of endothelial cells differentiated from bone marrow mesenchymal stem cells","volume":"43","author":"Wan","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jchf.2014.08.002_bib13","doi-asserted-by":"crossref","first-page":"e18683","DOI":"10.1371\/journal.pone.0018683","article-title":"Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury","volume":"6","author":"Kolatsi-Joannou","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jchf.2014.08.002_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/ATVBAHA.107.159160","article-title":"Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction","volume":"28","author":"Papaspyridonos","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jchf.2014.08.002_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","article-title":"Galectin-3 mediates aldosterone-induced vascular fibrosis","volume":"33","author":"Calvier","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jchf.2014.08.002_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/eurjhf\/hfr151","article-title":"Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial","volume":"14","author":"Lopez-Andr\u00e8s","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2014.08.002_bib17","doi-asserted-by":"crossref","first-page":"e000760","DOI":"10.1161\/JAHA.112.000760","article-title":"Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure","volume":"1","author":"Gopal","year":"2012","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jchf.2014.08.002_bib18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/07853890.2010.538080","article-title":"Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction","volume":"43","author":"De Boer","year":"2011","journal-title":"Ann Med"},{"key":"10.1016\/j.jchf.2014.08.002_bib19","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/(SICI)1097-0177(199804)211:4<306::AID-AJA2>3.0.CO;2-L","article-title":"Embryonic implantation in galectin 1\/galectin 3 double mutant mice","volume":"211","author":"Colnot","year":"1998","journal-title":"Dev Dyn"},{"key":"10.1016\/j.jchf.2014.08.002_bib20","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","article-title":"How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart\u00a0failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography\u00a0Associations of the European Society of Cardiology","volume":"28","author":"Paulus","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2014.08.002_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCHEARTFAILURE.112.971168","article-title":"Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis","volume":"6","author":"Yu","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2014.08.002_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/glycob\/cwj035","article-title":"Exploring the role of galectin 3 in kidney function: a genetic approach","volume":"16","author":"Bichara","year":"2006","journal-title":"Glycobiology"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177914003886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177914003886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:49:16Z","timestamp":1761972556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177914003886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S2213177914003886"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2014.08.002","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Galectin-3 Inhibition on\u00a0Aldosterone-Induced Cardiac and Renal\u00a0Injuries","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2014.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}